Prevalence of Cardiovascular Disease and Rate of Major Adverse Cardiovascular Events in Severe Alpha-1 Antitrypsin Deficiency COPD.
Journal Information
Full Title: Int J Chron Obstruct Pulmon Dis
Abbreviation: Int J Chron Obstruct Pulmon Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pulmonary Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure PE has received speaker fees from Chiesi, GSK, and AstraZeneca. AT has had grants and/or honoraria from AstraZeneca, GSK, Chiesi, CSLBehring, Vertex, and Grifols. KEH has received consulting income from AlphaNet. RS is employed by AlphaNet, reports personal fees from Grifols and CSL Behring, non-financial support from Inhibrx and Arrowhead, and grants from Matrx, outside the submitted work. EB, RC, and MN have no conflicts of interest."
"This project was supported by a grant from CHEST foundation."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025